HUP9900868A2 - Heterológ gének kromoszomális expressziója bakteriális sejtekben - Google Patents

Heterológ gének kromoszomális expressziója bakteriális sejtekben

Info

Publication number
HUP9900868A2
HUP9900868A2 HU9900868A HUP9900868A HUP9900868A2 HU P9900868 A2 HUP9900868 A2 HU P9900868A2 HU 9900868 A HU9900868 A HU 9900868A HU P9900868 A HUP9900868 A HU P9900868A HU P9900868 A2 HUP9900868 A2 HU P9900868A2
Authority
HU
Hungary
Prior art keywords
bacterial cells
heterologous genes
chromosomal expression
transfer dna
heterologous
Prior art date
Application number
HU9900868A
Other languages
English (en)
Inventor
Desmond Mascarenhas
Pamela S. Olson
Original Assignee
Celtrix Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celtrix Pharmaceuticals, Inc. filed Critical Celtrix Pharmaceuticals, Inc.
Publication of HUP9900868A2 publication Critical patent/HUP9900868A2/hu
Publication of HUP9900868A3 publication Critical patent/HUP9900868A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A találmány tárgyát heterőlóg fehérjék bakteriális gazdasejtekben,azaz példáűl Escherichia cőli-ban való előállítására szőlgálóeljárásők és készítmények képezik, egy krőmőszőmális transzfer DNS-nek(egy cirkűláris, önmagában való replikációra képtelen DNS) egygazdasejt krőmőszómájába való integrációja révén. A krőmőszómálistranszfer DNS egy vagy több kópiát tartalmaz az értékes heterőlógfehérjét kódőló génből. ŕ
HU9900868A 1995-06-07 1996-06-05 Chromosomal expression of heterologous genes in bacterial cells HUP9900868A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/482,182 US5861273A (en) 1993-12-21 1995-06-07 Chromosomal expression of heterologous genes in bacterial cells

Publications (2)

Publication Number Publication Date
HUP9900868A2 true HUP9900868A2 (hu) 1999-06-28
HUP9900868A3 HUP9900868A3 (en) 2000-04-28

Family

ID=23915047

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900868A HUP9900868A3 (en) 1995-06-07 1996-06-05 Chromosomal expression of heterologous genes in bacterial cells

Country Status (13)

Country Link
US (1) US5861273A (hu)
EP (1) EP0859782A4 (hu)
JP (1) JP3358818B2 (hu)
KR (1) KR19990022717A (hu)
CN (1) CN1190403A (hu)
AU (1) AU697444B2 (hu)
CA (1) CA2223494A1 (hu)
CZ (1) CZ394497A3 (hu)
HU (1) HUP9900868A3 (hu)
NO (1) NO975748L (hu)
NZ (1) NZ309645A (hu)
PL (1) PL323746A1 (hu)
WO (1) WO1996040722A1 (hu)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720140B1 (en) 1995-06-07 2004-04-13 Invitrogen Corporation Recombinational cloning using engineered recombination sites
US5851808A (en) 1997-02-28 1998-12-22 Baylor College Of Medicine Rapid subcloning using site-specific recombination
US5914390A (en) * 1997-05-12 1999-06-22 Celtrix Pharmaceuticals, Inc. Methods for increasing yields of recombinant proteins
US6436897B2 (en) 1998-06-01 2002-08-20 Celtrix Pharmaceuticals, Inc. Pharmaceutical formulations for IGF/IGFBP
US6417330B1 (en) * 1998-06-01 2002-07-09 Celtrix Pharmaceuticals, Inc. Insulin-like growth factor binding protein variants
JP2002521070A (ja) * 1998-07-31 2002-07-16 ジェン−プローブ・インコーポレーテッド 可逆的阻害プローブ
US7288516B1 (en) 1999-09-20 2007-10-30 Celtrix Pharmaceuticals, Inc. Null IGF for the treatment of cancer
WO2000052027A1 (en) 1999-03-02 2000-09-08 Invitrogen Corporation Compositions and methods for use in recombinational cloning of nucleic acids
US6268178B1 (en) 1999-05-25 2001-07-31 Phage Biotechnology Corp. Phage-dependent super-production of biologically active protein and peptides
DE19941186A1 (de) * 1999-08-30 2001-03-01 Peter Droege Sequenz-spezifische DNA-Rekombination in eukaryotischen Zellen
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US20030035788A1 (en) * 2000-09-19 2003-02-20 Desmond Mascarenhas Method for use of IGF-binding protein for selective sensitization of target cells in vivo
US6887851B2 (en) * 2001-09-18 2005-05-03 Bioexpertise, Llc IGF-binding protein-derived peptide
ATE382364T1 (de) * 2001-09-18 2008-01-15 Bioexpertise Llc Von igf-bindungsprotein stammendes peptid
WO2005110493A2 (en) * 2004-04-16 2005-11-24 Bioexpertise Llc Methods for delivering mbd peptide-linked agent into cells under conditions of cellular stress
US6914049B2 (en) * 2001-09-18 2005-07-05 Bioexpertise, Llc IGF-binding protein-derived peptide or small molecule
US7122715B2 (en) * 2001-09-20 2006-10-17 Monsanto Technology Llc In vitro method to create circular molecules for use in transformation
US6982038B2 (en) * 2002-06-14 2006-01-03 Medtronic, Inc. Centrifuge system utilizing disposable components and automated processing of blood to collect platelet rich plasma
WO2004033471A2 (en) 2002-10-04 2004-04-22 Genencor International, Inc. Glucose transport mutants for production of biomaterial
TW200502390A (en) 2002-11-28 2005-01-16 Peter Droege Sequence specific DNA recombination in eukaryotic cells
WO2004113382A1 (en) * 2003-06-13 2004-12-29 Insmed, Inc. Recombinant igf expression systems
WO2005054438A2 (en) 2003-12-01 2005-06-16 Invitrogen Corporation Nucleic acid molecules containing recombination sites and methods of using the same
ATE466107T1 (de) 2004-07-01 2010-05-15 Gen Probe Inc Verfahren und zusammensetzungen zum nachweis von nukleinsäuren in einer biologischen probe
US20060204979A1 (en) * 2004-12-01 2006-09-14 Invitrogen Corporation Reverse two-hybrid system for identification of interaction domains
US7611893B2 (en) 2005-11-09 2009-11-03 Ontherix, Inc. Metal-binding therapeutic peptides
US7662624B2 (en) * 2005-11-09 2010-02-16 Ontherix, Inc. Metal-binding therapeutic peptides
US20080039393A1 (en) * 2005-11-09 2008-02-14 Desmond Mascarenhas Metal-binding therapeutic peptides
EP1945263A4 (en) * 2005-11-09 2012-09-26 Ontherix Inc THERAPEUTIC PEPTIDES BINDING TO METALS
WO2008142028A1 (en) 2007-05-17 2008-11-27 Boehringer Ingelheim Rcv Gmbh & Co Kg Method for producing a recombinant protein on a manufacturing scale
US8536135B2 (en) * 2008-03-19 2013-09-17 Ontherix, Inc. Adaptive biochemical signatures
WO2010024905A1 (en) * 2008-08-27 2010-03-04 Massachusetts Institute Of Technology Genetically stabilized tandem gene duplication
WO2010068473A1 (en) * 2008-11-25 2010-06-17 Gen-Probe Incorporated Compositions and methods for detecting small rnas, and uses thereof
JP2012196144A (ja) 2009-08-03 2012-10-18 Ajinomoto Co Inc ビブリオ属細菌を用いたｌ−リジンの製造法
WO2019123324A1 (en) 2017-12-21 2019-06-27 Glycom A/S Nucleic acid construct for in vitro and in vivo gene expression

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704362A (en) * 1977-11-08 1987-11-03 Genentech, Inc. Recombinant cloning vehicle microbial polypeptide expression
US4563424A (en) * 1979-11-05 1986-01-07 Genentech, Inc. Method and means for somatostatin protein conjugate expression
US4425437A (en) * 1979-11-05 1984-01-10 Genentech, Inc. Microbial polypeptide expression vehicle
US4431739A (en) * 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
FR2563533B1 (fr) * 1984-04-27 1986-08-22 Centre Nat Rech Scient Procede d'amplification de l'expression d'un gene determine chez bacillus subtilis et souches obtenues
AU620326B2 (en) * 1987-02-27 1992-02-20 Dsm Ip Assets B.V. Stable gene amplification in chromosomal dna of prokaryotic microorganisms
US5196318A (en) * 1990-06-26 1993-03-23 The Texas A&M University System Precisely regulated expression of deleterious genes
US5470727A (en) * 1993-12-21 1995-11-28 Celtrix Pharmaceuticals, Inc. Chromosomal expression of non-bacterial genes in bacterial cells

Also Published As

Publication number Publication date
WO1996040722A1 (en) 1996-12-19
NO975748L (no) 1998-01-19
CA2223494A1 (en) 1996-12-19
PL323746A1 (en) 1998-04-14
AU5986496A (en) 1996-12-30
EP0859782A4 (en) 2002-11-06
KR19990022717A (ko) 1999-03-25
US5861273A (en) 1999-01-19
JPH11507521A (ja) 1999-07-06
EP0859782A1 (en) 1998-08-26
NZ309645A (en) 1998-12-23
HUP9900868A3 (en) 2000-04-28
CZ394497A3 (cs) 1998-06-17
NO975748D0 (no) 1997-12-05
CN1190403A (zh) 1998-08-12
AU697444B2 (en) 1998-10-08
JP3358818B2 (ja) 2002-12-24

Similar Documents

Publication Publication Date Title
HUP9900868A2 (hu) Heterológ gének kromoszomális expressziója bakteriális sejtekben
AU4882296A (en) DNA molecules, preparation and use in gene therapy
EP1541690A3 (en) Transfer of mRNA using polycationic compounds
ATE352638T1 (de) REVERSE ßTWO-HYBRIDß-SYSTEME
CY1106408T1 (el) Γονιδιωματικη αλληλουχια του χλαμυδιου της πνευμονιας (chlamydia pneymoniae) και πολυπεπτιδια, τμηματα αυτων και χρησεις αυτων, ιδιως για τη διαγνωση, την προληψη και τη θepαπευτικη αντιμετωπιση λοιμωξης
PT832264E (pt) Plasmideo para a transferencia de acidos nucleicos a celulas e metodos de utilizacao.
HUP9900018A1 (hu) Cirkuláris DNS-molekula feltételes replikációs origóval, eljárás előállítására és génterápiában való felhasználására
DK0941352T3 (da) Forbedring af stivelsesindholdet i planter
DE69128893T2 (de) Genetische veränderung von endothelzellen
DK0941318T5 (da) Håndvægtformede konstruerede ekspressionssystemer til genterapi
AU1367897A (en) A method for in vivo production of a mutant library in cells
EP0804609A4 (en) NEW GENES OF RESPONSE p53
HK1045326A1 (zh) 微生物的β-葡萄糖甘酸酶基因，基因產品及其用法
CA2179656A1 (en) Chromosomal expression of heterologous genes in bacterial cells
CY1109797T1 (el) Μορια πυρηνικου οξεος, κωδικοποιουντα ενζυμα, τα οποια διαθετουν δραστηριοτητα φρουκτοζυλικης τρανσφερασης, και η χρηση αυτων
McPherson et al. Two class A high-molecular-weight penicillin-binding proteins of Bacillus subtilis play redundant roles in sporulation
ATE310085T1 (de) Cyclin-e2 proteine und dafür kodierende gene
Ansaldi et al. The TorR high-affinity binding site plays a key role in both torR autoregulation and torCAD operon expression in Escherichia coli
AU1727597A (en) Purified sr-p70 protein
EP0195285A3 (en) Molecular cloning of the delta-endotoxin gene of bacillus thurigiensis var. israelensis
HUP9900750A2 (hu) Gén kifejezésére szolgáló promóterek
AU1935399A (en) Nucleotide and protein sequence of mammastatin and methods of use
AU1099697A (en) Novel xylanases, genes encoding them, and uses thereof
Williams et al. Identification and genetic mapping of the structural gene for an essential Escherichia coli membrane protein
NO20020665L (no) Streptomyces Avermitilis gen som bestemmer forholdet B2:B1 avermectiner